World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01397396
Date of registration: 18/07/2011
Primary sponsor: Katholieke Universiteit Leuven
Public title: Effects of Inspiratory Muscle Training in COPD IMTCO
Scientific title: Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial
Date of first enrolment: September 2011
Target sample size: 160
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01397396
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
Belgium
Contacts
Name:   Daniel Langer, PT, PhD
Address: 
Telephone: 0032-16-330192
Email: daniel.langer@faber.kuleuven.be
Affiliation: 
Name:   Daniel Langer, PT, PhD
Address: 
Telephone: 0032-16-330192
Email: daniel.langer@faber.kuleuven.be
Affiliation: 
Name:   Rik Gosselink, PT, PhD
Address: 
Telephone:
Email:
Affiliation:  Katholieke Universiteit Leuven
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with COPD

- Eligible to participate in a exercise training intervention of 8 weeks

- Pi,max <60cmH2O or <50% of the predicted normal value

Exclusion Criteria:

- Major comorbidities preventing successful participation in an 8 week exercise
training intervention



Age minimum: 40 Years
Age maximum: 90 Years
Gender: Both
Health Condition(s) or Problem(s) studied
COPD
Inspiratory Muscle Weakness
Intervention(s)
Procedure: Inspiratory Muscle Training
Primary Outcome(s)
6-Minute Walking Distance [Time Frame: Baseline and 8 weeks follow-up]
Secondary Outcome(s)
Secondary ID(s)
S52852
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history